Related Experiment Video
Updated: Apr 17, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Maxillary sinus manifestations of methamphetamine abuse
Erynne A Faucett1, Katherine M Marsh, Kayven Farshad
1Department of Otolaryngology-Head and Neck Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA.
Methamphetamine abuse can lead to serious dental problems like "meth mouth," increasing the risk of infections. This study details two cases of loculated purulent collections in the maxillary sinus linked to methamphetamine use.
Area of Science:
- Otolaryngology
- Oral and Maxillofacial Surgery
- Infectious Diseases
Background:
- Methamphetamine is a widely abused illicit drug with significant health and economic impacts.
- Commonly known effects include dental issues (
- meth mouth
- ) but maxillary sinus complications are less understood.
- Methamphetamine abuse is associated with poor oral hygiene and rampant dental caries.
Purpose of the Study:
- To investigate and delineate otolaryngologic symptoms in methamphetamine abusers.
- To highlight the presentation and management of maxillary sinus infections in this population.
- To explore the link between methamphetamine abuse and craniofacial infections.
Main Methods:
- Case study of two patients with a history of methamphetamine abuse.
- Clinical evaluation of otolaryngologic symptoms.
- Diagnostic imaging including computed tomography (CT) and magnetic resonance imaging (MRI).
Main Results:
- Both patients presented with loculated purulent collections within the maxillary sinus.
- Imaging revealed probable odontogenic origin for the collections.
- Findings suggest a predisposition to craniofacial infections and fluid collections due to methamphetamine-induced poor oral hygiene.
Conclusions:
- Methamphetamine abuse can contribute to severe maxillary sinusitis and mucoceles.
- Poor oral hygiene and dental caries associated with methamphetamine use are potential predisposing factors.
- This highlights a significant, underreported manifestation of methamphetamine abuse affecting the craniofacial region.
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Asthma III: Clinical Manifestations
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

